Lv52
818 积分 2022-10-25 加入
PEGylation of Dipeptide Linker Improves Therapeutic Index and Pharmacokinetics of Antibody-Drug Conjugates
13天前
已完结
Optimization of a pendant-shaped PEGylated linker for antibody-drug conjugates
13天前
已完结
PD‐L1 and nectin‐4 expression and genomic characterization of bladder cancer with divergent differentiation
1个月前
已完结
Nectin-4: A promising prognostic marker and therapeutic target in cancer
1个月前
已关闭
Nectin-4 Expression Patterns and Therapeutics in Oncology
1个月前
已完结
Nectin-4-directed antibody-drug conjugates (ADCs): Spotlight on preclinical and clinical evidence
1个月前
已完结
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
2个月前
已完结
The old CEACAMs find their new role in tumor immunotherapy
2个月前
已完结
A novel bispecific antibody drug conjugate targeting HER2 and HER3 with potent therapeutic efficacy against breast cancer
5个月前
已完结
Pharmacokinetics of Tarlatamab, a Delta-Like Ligand-3 (DLL3) Targeted Half-Life Extended Bispecific T-Cell Engager (BiTE®) Immunotherapy in Adult Patients with Previously Treated Small-Cell Lung Cancer: Results from DeLLphi-300, a Phase I Multiple-Dose-Escalation Study
6个月前
已完结
皖公网安备34019202002308
